← Back to screener

Astrana Health, Inc. ASTH

Rank #1099 · Nasdaq · $2.0B market cap
Audited by Ernst & Young LLP, no going-concern flag in the latest filing.
Score
53.6
P/E
33.5
P/B
2.86
ROE
8.5%
Op. Margin
6.1%
Debt Ratio
118%

Health Check — percentile rank within this universe, based on the latest annual filing

Valuation ★★★☆☆
Average

P/E 33.5x, P/B 2.86x. Ranks in the top 46% of the universe.

Profitability ★★☆☆☆
Average

ROE 8.5%. Ranks in the top 53% of the universe.

Safety ★★★☆☆
Average

Debt ratio 118%. Ranks in the top 45% of the universe.

Growth ★★★★☆
Excellent

Revenue growth of 21.2% year over year. Ranks in the top 18% of the universe.

Growth is the relative strength · Profitability is the relative weakness (relative to this universe).

Financials annual, from SEC 10-K filings

FYRevenueOp. IncomeNet IncomeEquityOp. Margin%Debt%
2011$0.0B$0.0B$-0.0B$-0.0B0.1-431
2012$0.0B$-0.0B$-0.0B$-0.0B-8.1-271
2013$0.0B$-0.0B$-0.0B$-0.0B-26.7-1019
2015$0.0B$-0.0B$-0.0B$-0.0B-37.3-216
2016$0.0B$-0.0B$-0.0B$-0.0B-2.1-567
2017$0.0B$0.0B$0.0B$0.1B26.5114
2018$0.4B$0.0B$0.0B$0.2B9.996
2019$0.4B$0.0B$0.0B$0.2B9.959
2020$0.5B$0.1B$0.0B$0.2B17.0192
2021$0.6B$0.0B$0.0B$0.3B5.8113
2022$0.7B$0.1B$0.0B$0.5B11.774
2023$0.8B$0.1B$0.1B$0.5B12.775
2024$1.1B$0.1B$0.0B$0.6B9.185
2025$1.4B$0.1B$0.1B$0.7B6.1118

← See the full screener